Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone

Human Pathology

Volumn 45, Issue 8, 2014, Pages 1664-1673

  Wu, Peng Yan ^a,b   Zhang, Xu Dong ^b,c   Zhu, Jiang ^d   Guo, Xiang Yun ^b   Wang, Jin Fen ^b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b SHANXI CANCER HOSPITAL   (China)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

CHOP; Diffuse large B cell lymphoma; MiR 146b 5p; MiR 320d; Outcome

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; MICRORNA; MICRORNA 146B 5P; MICRORNA 320D; MYC PROTEIN; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE;

CHOP; DIFFUSE LARGE B-CELL LYMPHOMA; MIR-146B-5P; MIR-320D; OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL PROLIFERATION; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; GENOTYPE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICRORNAS; MIDDLE AGED; PHARMACOGENETICS; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; VINCRISTINE;

EID: 84904686964     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.04.002     Document Type: Article

References (32)

1. E. Sabattini, F. Bacci, and C. Sagramoso et al. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview Pathologica 102 2010 83 87
2. L.M. Morton, S.S. Wang, and S.S. Devesa et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood 107 2006 265 276
3. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
4. M. Ozbalak, M.C. Ar, and N. Tuzuner et al. Detailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective study ISRN Hematol 2013 10.1155/2013/908191
5. D. Rossi, V. Spina, and C. Deambrogi et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation Blood 117 2011 3391 3401
6. J.J. Muris, C.J. Meijer, and W. Vos et al. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma J Pathol 208 2006 714 723
7. M. Martelli, A.J. Ferreri, and C. Agostinelli et al. Diffuse large B-cell lymphoma Crit Rev Oncol Hematol 87 2013 146 171
8. J. Lu, G. Getz, and E.A. Miska et al. MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
9. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20
10. S. Sethi, S. Ali, and D. Kong et al. Clinical implication of MicroRNAs in molecular pathology Clin Lab Med 33 2013 773 786
11. H. Bai, J. Wei, and C. Deng et al. MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen Int J Hematol 97 2013 223 231
12. A.J. Alencar, R. Malumbres, and G.A. Kozloski et al. MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP Clin Cancer Res 17 2011 4125 4135
13. S.K. Sandhu, S. Volinia, and S. Costinean et al. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6(BCL6) in the Eμ-miR-155 transgenic mouse model Proc Natl Acad Sci U S A 109 2012 20047 20052
14. M. He, L. Gao, and S. Zhang et al. Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL Gastric Cancer 2013 10.1007/s10120-013-0313-3
15. D.A. Shephard The 1975 Declaration of Helsinki and consent Can Med Assoc J 115 1976 1191 1192
16. C.P. Hans, D.D. Weisenburger, and T.C. Greiner et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Blood 103 2004 275 282
17. T.M. Habermann, E.A. Weller, and V.A. Morrison et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma J Clin Oncol 24 2006 3121 3127
18. Y. Huang, S. Ye, and Y. Cao et al. Outcome of R-CHOP or CHOP regimen for germinal center and nongerminal center subtypes of diffuse large B-cell lymphoma of Chinese patients Sci World J 2012 10.1100/2012/897178
19. S.W. Kim, K. Ramasamy, and H. Bouamar et al. MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) Proc Natl Acad Sci U S A 109 2012 7865 7870
20. X. Huang, Y. Shen, and M. Liu et al. Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma Am J Pathol 181 2012 26 33
21. A. Bronisz, J. Godlewski, and J.A. Wallace et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320 Nat Cell Biol 14 2011 159 167
22. T. Schepeler, J.T. Reinert, and M.S. Ostenfeld et al. Diagnostic and prognostic microRNAs in stage II colon cancer Cancer Res 68 2008 6416 6424
23. M.V. Geraldo, A.S. Yamashita, and E.T. Kimura MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer Oncogene 31 2012 1910 1922
24. Y. Li, Y. Wang, and L. Yu et al. miR-146b-5p inhibits glioma migration and invasion by targeting MMP16 Cancer Lett 339 2013 260 269
25. S. Lee, J.W. Jung, and S.B. Park et al. Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord blood-derived multipotent stem cell aging Cell Mol Life Sci 68 2011 325 336
26. Q. Li, G. Wang, and J.L. Shan et al. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion J Gastroenterol Hepatol 25 2010 164 171
27. C.M. Gits, P.F. van Kuijk, and M.B. Jonkers et al. MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours Br J Cancer 109 2013 1625 1635
28. J. Pan, H. Hu, and Z. Zhou et al. Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells Oncol Rep 24 2010 105 112
29. K.J. Savage, N.A. Johnson, and S. Ben-Neriah et al. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy Blood 114 2009 3533 3537
30. C. Li, S.W. Kim, and D. Rai et al. Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma Blood 113 2009 6681 6690
31. T.C. Chang, D. Yu, and Y.S. Lee et al. Widespread microRNA repression by Myc contributes to tumorigenesis Nat Genet 40 2008 43 50
32. S. Bhatia, D. Kaul, and N. Varma Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia Mol Cell Biochem 340 2010 97 106